Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
Many neuropsychiatric symptoms of fragile X syndrome (FXS) are believed to be a consequence of altered regulation of protein synthesis at synapses. We discovered that lovastatin, a drug that is widely prescribed for the treatment of high cholesterol, can correct excess hippocampal protein synthesis...
Main Authors: | Chuang, Shih-Chieh, Chubykin, Alexander A., Sidorov, Michael, Bianchi, Riccardo, Wong, Robert K.S., Osterweil, Emily, Bear, Mark, Chubykin, Alexander A. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2016
|
Online Access: | http://hdl.handle.net/1721.1/102250 https://orcid.org/0000-0003-0582-2284 |
Similar Items
-
Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
by: Osterweil, Emily, et al.
Published: (2011) -
Lifting the Mood on Treating Fragile X
by: Kind, Peter C., et al.
Published: (2016) -
Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome
by: Krueger, Dilja, et al.
Published: (2011) -
A Cholinergic Mechanism for Reward Timing within Primary Visual Cortex
by: Chubykin, Alexander A., et al.
Published: (2016) -
Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?
by: Lohith, Talakad G., et al.
Published: (2013)